TL;DR
This study reveals a significant negative association between serum uric acid levels and lung function (FEV1 and FVC) in US adults, even after accounting for numerous confounding factors. This finding suggests uric acid may play a role in lung health decline and could potentially serve as a biomarker for impaired lung function.
What Problem Does This Paper Address?
Lung function naturally declines with age and can be affected by various health conditions, increasing the risk of respiratory diseases and mortality. Identifying reliable biomarkers that can predict or indicate impaired lung function is crucial for early intervention and better health outcomes. While serum uric acid has been linked to various cardiovascular and respiratory conditions, its specific relationship with lung function has been inconsistent across previous studies, with some showing negative associations, some positive, and others gender-specific effects. This paper aims to clarify this controversial relationship by investigating whether serum uric acid has an independent association with lung function in a large, representative US adult population.
Methods
The researchers utilized data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2012. They employed multivariable linear regression models to analyze the association between serum uric acid (the exposure variable) and lung function measures, specifically forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) (the outcome variables). Crucially, these analyses were adjusted for a comprehensive set of potential confounders, including age, gender, race, body mass index (BMI), alcohol consumption, smoking status, systolic and diastolic blood pressure, blood urea nitrogen, creatinine, calcium, total cholesterol, total protein, fractional exhaled nitric oxide (FeNO), and total bilirubin. Generalized additive models were also used to explore potential non-linear relationships. Subgroup and interaction analyses were performed to ensure the robustness of the findings.
Datasets
The study used data from the National Health and Nutrition Examination Survey (NHANES) for the years 2007-2012. This is a publicly available, complex, stratified, multistage probability sample survey of the non-institutionalized US population, designed to assess health and nutritional status. The researchers included 7514 participants after applying specific exclusion criteria.
Key Insights and Ideas
- Consistent Negative Association: The most striking finding is the robust and consistent negative association between serum uric acid and lung function (FEV1 and FVC) across the entire US adult population studied, regardless of gender. This challenges previous conflicting results and provides a clearer picture.
- Independent Relationship: The study's strength lies in its rigorous adjustment for a wide array of potential confounders. This suggests that the observed negative association is likely independent of common factors that influence both uric acid levels and lung function.
- Potential Biomarker Role: The consistent negative relationship hints at uric acid's potential as a biomarker for impaired lung function, prompting further investigation into its role in the pathophysiology of lung health decline.
- Subgroup Robustness: The association remained consistent across various subgroups (age, race, BMI, smoking, alcohol consumption), reinforcing the reliability of the findings.
Key Results
After adjusting for confounders, a 1 mg/dl increase in serum uric acid was associated with a significant decline in lung function:
- FEV1: A decrease of 24.77 ml (95% CI: -36.11 to -13.43).
- FVC: A decrease of 32.93 ml (95% CI: -47.42 to -18.45).
These negative associations were significant in both male and female populations and remained consistent across various subgroup analyses.
Limitations and Future Work
The authors acknowledge several limitations:
- Cross-sectional Design: The study's cross-sectional nature prevents establishing a causal relationship between serum uric acid and lung function.
- Medication Use: The use of uric acid-lowering medications was not accounted for, although individuals with gout were excluded.
- Generalizability: While the NHANES dataset is representative, the specific exclusion criteria applied might limit the generalizability of findings to certain populations.
Future work should focus on:
- Causal Mechanisms: Investigating the underlying pathophysiological mechanisms that link serum uric acid to lung function decline.
- Prospective Studies: Conducting longitudinal studies to confirm the causal relationship and explore the predictive value of serum uric acid for lung function decline.
- Intervention Studies: Exploring whether interventions to lower uric acid levels can positively impact lung function.
Summary updated